Vivalink, a digital healthcare solutions provider, has launched a new ambulatory cardiac solution for mobile cardiac telemetry (MCT) and Holter monitoring.

The new solution combines remote patient monitoring (RPM) technologies with advanced arrhythmia detection algorithms to streamline deployment and enhance patient care.

This integration is aimed at addressing the increasing demand for solutions that cater to ambulatory ECG monitoring.

The advanced arrhythmia detection algorithm can identify more than 15 common arrhythmias and ectopic beats.

The solution features a reusable ECG patch with a 14-day rechargeable battery and data storage capacity for up to 30 days.

It includes a provisioned mobile gateway paired with a patient app for seamless data transmission and patient engagement.

The technology also offers customisable final ECG report generation to meet the specific needs of clinicians.

A portal is available for over-read and annotation, providing clinicians with actionable insights for informed decision-making.

Vivalink said that partners can streamline the delivery and minimise the ambulatory cardiac monitoring services’ cost using a common technology solution for both MCT and Holter.

Vivalink CEO Jiang Li said: “Bringing together cutting-edge technology and medical expertise, Vivalink's turnkey technology solution is changing the landscape of ambulatory cardiac monitoring.

“Our integrated solution simplifies the deployment of remote cardiac monitoring services, offering a seamless implementation for our partners.”

Last month, Vivalink and Rett Syndrome Research Trust (RSRT) collaborated to advance research into Rett syndrome, a rare neurological disorder.

As part of the collaboration, Vivalink agreed to provide its multi-vital ECG wearable technology and data services for heart rate and oxygen saturation monitoring to support the new VIBRANT study by RSRT.

The study is designed to assess autonomic dysfunction in individuals with Rett syndrome.